Geneos Wealth Management’s Camtek CAMT Stock Holding History

Geneos Wealth Management’s Portfolio CAMT Stock Details CAMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-35	Closed	-$2.83K	–	3085
2024 Q4	$2.83K	Hold	35	–	–	﹤0.01%	2506
2024 Q3	$2.79K	Buy	+35	New	+$3.41K	﹤0.01%	2215
2021 Q4	–	Sell	-265	Closed	-$11K	–	2778
2021 Q3	$11K	Buy	+265	New	+$10.2K	﹤0.01%	2172
2021 Q2	–	Sell	-178	Closed	-$6K	–	2883
2021 Q1	$6K	Hold	178	–	–	﹤0.01%	2580
2020 Q4	$5K	Buy	+178	New	+$3.41K	﹤0.01%	2452
2020 Q3	–	Sell	-2,000	Closed	-$24K	–	2637
2020 Q2	$24K	Hold	2,000	–	–	﹤0.01%	1533
2020 Q1	$16K	Hold	2,000	–	–	﹤0.01%	1600
2019 Q4	$21K	Hold	2,000	–	–	﹤0.01%	1650
2019 Q3	$18K	Hold	2,000	–	–	﹤0.01%	1646
2019 Q2	$16K	Buy	+2,000	New	+$18.4K	﹤0.01%	1733

Other funds holding CAMT

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

UIM

USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Geneos Wealth Management's CAMT Position: Q1 2025 in Review

Geneos Wealth Management sold out of Camtek (CAMT) in Q1 2025, closing a stake of 35 shares — an estimated $2.83K sold.

Geneos Wealth Management first reported a position in CAMT in Q2 2019 and held it in 10 quarters. The position peaked at $24K in Q2 2020. 169 funds tracked by Wall St. Rank hold CAMT as of Q1 2025.

Geneos Wealth Management reported no remaining Camtek position as of Q1 2025 after selling out during the quarter.
Geneos Wealth Management sold 35 Camtek shares in Q1 2025, an estimated $2.83K.
Geneos Wealth Management first reported a position in Camtek in Q2 2019 and held it in 10 quarters.
Geneos Wealth Management's Camtek position peaked at $24K in Q2 2020.
169 funds tracked by Wall St. Rank held Camtek as of Q1 2025.

Based on Geneos Wealth Management's 13F filing for Q1 2025, filed 8 May 2025.